To the best of our knowledge, plasma levels of BCAN and Nr-CAM have not been previously investigated in a stroke cohort, but others have used the same protein panel as us in search of plasma biomarkers of other central nervous system (CNS) phenotypes. The gene discussed is BCAN; the disease is stroke disorder.